B37.5 Candidal meningitis

Name of the Condition

• Candidal Meningitis (ICD Code: B37.5)
• Technical term: Candidal meningitis
• ICD-10 Code: B37.5

Summary

Candidal meningitis is a fungal infection of the meninges, the protective membranes surrounding the brain and spinal cord, caused by Candida species. It is a serious condition that can lead to inflammation, neurological symptoms, and potential complications. The infection typically arises from the spread of Candida from other body sites, such as the bloodstream, and requires prompt medical attention.

Causes

Candidal meningitis occurs when Candida fungi invade the meninges, often through hematogenous spread from a systemic infection or direct extension from adjacent structures. The overgrowth of Candida, which is normally present in small amounts in the body, can be triggered by factors that disrupt immune function or create opportunities for fungal dissemination.

Risk Factors

• Weakened immune system (e.g., HIV/AIDS, chemotherapy, organ transplantation).
• Prolonged use of broad-spectrum antibiotics or corticosteroids.
• Central nervous system (CNS) procedures (e.g., neurosurgery, lumbar puncture).
• Indwelling medical devices (e.g., ventricular shunts, intravenous catheters).
• Diabetes mellitus or poorly controlled blood sugar.
• Premature birth or low birth weight in neonates.

Symptoms

• Severe headache.
• Fever and chills.
• Stiff neck (nuchal rigidity).
• Nausea and vomiting.
• Sensitivity to light (photophobia).
• Altered mental status or confusion.
• Seizures.
• Focal neurological deficits (e.g., weakness, numbness).

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., MRI or CT of the brain), and laboratory tests. A lumbar puncture is typically performed to analyze cerebrospinal fluid (CSF) for fungal elements, elevated white blood cell count, and abnormal protein or glucose levels. CSF cultures or PCR testing may confirm the presence of Candida species.

Treatment Options

Treatment usually includes antifungal medications, such as fluconazole, amphotericin B, or echinocandins, administered intravenously. The choice of drug and duration depend on the severity of the infection and the patient’s immune status. Supportive care, including management of increased intracranial pressure, may also be necessary.

Prognosis and Follow-Up

Prognosis varies based on the patient’s overall health, timeliness of treatment, and presence of underlying conditions. Early intervention improves outcomes, but severe cases or immunocompromised patients may have higher mortality rates. Follow-up includes monitoring for recurrence, neurological recovery, and addressing any residual complications.

Complications

• Permanent neurological damage (e.g., cognitive impairment, motor deficits).
• Hydrocephalus (accumulation of CSF in the brain).
• Seizure disorders.
• Death, particularly in untreated or severe cases.

Lifestyle & Prevention

• Maintain good hygiene and manage underlying conditions (e.g., diabetes).
• Avoid unnecessary use of antibiotics or corticosteroids when possible.
• Ensure proper care of indwelling medical devices to reduce infection risk.
• For immunocompromised individuals, follow preventive measures recommended by healthcare providers.

When to Seek Professional Help

Seek immediate medical attention if experiencing severe headache, fever, stiff neck, or neurological symptoms, as these may indicate meningitis. Prompt evaluation is critical to prevent serious complications.

Tips for Medical Coders

Document the presence of Candida species in CSF or other relevant specimens to support the diagnosis. Include details about the infection’s source (e.g., systemic candidiasis) and any associated risk factors (e.g., immunosuppression) to ensure accurate coding. Verify that the code B37.5 is used for candidal meningitis and not for other CNS fungal infections.